Exchange: NASDAQ·Updated 04:41 PM EDT
CTSO logo

CTSO Cytosorbents Corp

$0.36
$0.0054
(1.61%)
Today
Closed $0.341
$0.019
(5.57%)
After Hours
Reported EarningsAug 6
Mkt Cap$21.09M
Vol111,591.00

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin in August 1997 and is headquartered in Princeton, NJ.
58

Bullish Sentiment

How do you feel about CTSO?

Advertisement|Remove ads.